Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2007-11-16
pubmed:abstractText
Tools for monitoring modern target-specific antiangiogenic and antivascular therapies are highly desirable because treatment strategies are time consuming, expensive, and yet sometimes ineffective. Therefore, the aim of this experimental study was to evaluate the predictive value of steady-state ultrasmall particles of iron oxide (USPIO; SH U 555 C)-enhanced magnetic resonance imaging (MRI) for early assessment of antivascular tumor-treatment effectiveness.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0020-9996
pubmed:author
pubmed:issnType
Print
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
791-6
pubmed:dateRevised
2009-11-11
pubmed:meshHeading
pubmed-meshheading:18007150-Angiogenesis Inhibitors, pubmed-meshheading:18007150-Animals, pubmed-meshheading:18007150-Cell Line, Tumor, pubmed-meshheading:18007150-Contrast Media, pubmed-meshheading:18007150-Female, pubmed-meshheading:18007150-Ferric Compounds, pubmed-meshheading:18007150-Fibrosarcoma, pubmed-meshheading:18007150-Humans, pubmed-meshheading:18007150-Magnetic Resonance Imaging, pubmed-meshheading:18007150-Mice, pubmed-meshheading:18007150-Mice, Nude, pubmed-meshheading:18007150-Oligopeptides, pubmed-meshheading:18007150-Predictive Value of Tests, pubmed-meshheading:18007150-Recombinant Fusion Proteins, pubmed-meshheading:18007150-Thromboplastin, pubmed-meshheading:18007150-Time Factors, pubmed-meshheading:18007150-Treatment Outcome, pubmed-meshheading:18007150-Xenograft Model Antitumor Assays
pubmed:year
2007
pubmed:articleTitle
Prediction of antiangiogenic treatment efficacy by iron oxide enhanced parametric magnetic resonance imaging.
pubmed:affiliation
Department of Clinical Radiology, University of Münster, Münster, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Evaluation Studies